{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T08:53:06Z","timestamp":1793782386496,"version":"4.6.1"},"reference-count":140,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NIEHS","award":["P30ES030283"],"award-info":[{"award-number":["P30ES030283"]}],"id":[{"id":"https:\/\/ror.org\/00j4k1h63","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["AR230178P1"],"award-info":[{"award-number":["AR230178P1"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08395-5","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T12:07:07Z","timestamp":1783426027000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Oxytocin and RAGE signaling at the intersection of social neurodevelopment and inflammation"],"prefix":"10.1186","volume":"24","author":[{"given":"Jaime","family":"Shoup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Sadle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Hui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Nagarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"8395_CR1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"AP Association","year":"2013","unstructured":"Association AP. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Association; 2013.","edition":"5"},{"key":"8395_CR2","unstructured":"Centers for Disease Control and Prevention (CDC). Prevalence and Characteristics of Autism Spectrum Disorder among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network. 2020 3\/24\/2023."},{"issue":"3","key":"8395_CR3","doi-asserted-by":"publisher","first-page":"635","DOI":"10.21037\/tp-21-54","volume":"10","author":"Z Yong","year":"2021","unstructured":"Yong Z, et al. Prenatal, perinatal, and postnatal factors associated with autism spectrum disorder cases in Xuzhou, China. Transl Pediatr. 2021;10(3):635\u201346.","journal-title":"Transl Pediatr"},{"key":"8395_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13229-017-0121-4","volume":"8","author":"A Modabbernia","year":"2017","unstructured":"Modabbernia A, Velthorst E, Reichenberg A. Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analyses. Mol Autism. 2017;8:13.","journal-title":"Mol Autism"},{"issue":"1","key":"8395_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13229-020-00370-1","volume":"11","author":"C Cheroni","year":"2020","unstructured":"Cheroni C, Caporale N, Testa G. Autism spectrum disorder at the crossroad between genes and environment: contributions, convergences, and interactions in ASD developmental pathophysiology. Mol Autism. 2020;11(1):69.","journal-title":"Mol Autism"},{"issue":"7","key":"8395_CR6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.molmed.2011.03.001","volume":"17","author":"PH Patterson","year":"2011","unstructured":"Patterson PH. Maternal infection and immune involvement in autism. Trends Mol Med. 2011;17(7):389\u201394.","journal-title":"Trends Mol Med"},{"issue":"1","key":"8395_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41398-022-01843-y","volume":"12","author":"P Ellul","year":"2022","unstructured":"Ellul P, et al. Parental autoimmune and autoinflammatory disorders as multiple risk factors for common neurodevelopmental disorders in offspring: a systematic review and meta-analysis. Transl Psychiatry. 2022;12(1):112.","journal-title":"Transl Psychiatry"},{"issue":"8","key":"8395_CR8","doi-asserted-by":"publisher","first-page":"111677","DOI":"10.1016\/j.celrep.2022.111677","volume":"41","author":"DA Lopez","year":"2022","unstructured":"Lopez DA, et al. Prenatal inflammation perturbs murine fetal hematopoietic development and causes persistent changes to postnatal immunity. Cell Rep. 2022;41(8):111677.","journal-title":"Cell Rep"},{"issue":"12","key":"8395_CR9","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1007\/s10803-010-1006-y","volume":"40","author":"HO Atladottir","year":"2010","unstructured":"Atladottir HO, et al. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord. 2010;40(12):1423\u201330.","journal-title":"J Autism Dev Disord"},{"issue":"4","key":"8395_CR10","doi-asserted-by":"publisher","first-page":"e227503","DOI":"10.1001\/jamanetworkopen.2022.7503","volume":"5","author":"H He","year":"2022","unstructured":"He H, et al. Association of Maternal Autoimmune Diseases With Risk of Mental Disorders in Offspring in Denmark. JAMA Netw Open. 2022;5(4):e227503.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"8395_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41537-018-0051-y","volume":"4","author":"EJ Cadena","year":"2018","unstructured":"Cadena EJ, et al. Evaluation of fronto-striatal networks during cognitive control in unmedicated patients with schizophrenia and the effect of antipsychotic medication. NPJ Schizophr. 2018;4(1):8.","journal-title":"NPJ Schizophr"},{"issue":"8","key":"8395_CR12","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.biopsych.2016.08.009","volume":"81","author":"MM Vaghi","year":"2017","unstructured":"Vaghi MM, et al. Specific Frontostriatal Circuits for Impaired Cognitive Flexibility and Goal-Directed Planning in Obsessive-Compulsive Disorder: Evidence From Resting-State Functional Connectivity. Biol Psychiatry. 2017;81(8):708\u201317.","journal-title":"Biol Psychiatry"},{"issue":"10","key":"8395_CR13","doi-asserted-by":"publisher","first-page":"e916","DOI":"10.1038\/tp.2016.161","volume":"6","author":"AM D\u2019Cruz","year":"2016","unstructured":"D\u2019Cruz AM, et al. Alterations in the functional neural circuitry supporting flexible choice behavior in autism spectrum disorders. Transl Psychiatry. 2016;6(10):e916.","journal-title":"Transl Psychiatry"},{"key":"8395_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fnins.2016.00027","volume":"10","author":"MV Fuccillo","year":"2016","unstructured":"Fuccillo MV. Striatal Circuits as a Common Node for Autism Pathophysiology. Front Neurosci. 2016;10:27.","journal-title":"Front Neurosci"},{"issue":"6","key":"8395_CR15","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1001\/archpediatrics.2009.74","volume":"163","author":"WG Johnson","year":"2009","unstructured":"Johnson WG, et al. HLA-DR4 as a risk allele for autism acting in mothers of probands possibly during pregnancy. Arch Pediatr Adolesc Med. 2009;163(6):542\u20136.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"11","key":"8395_CR16","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.tins.2019.08.001","volume":"42","author":"U Meyer","year":"2019","unstructured":"Meyer U. Neurodevelopmental Resilience and Susceptibility to Maternal Immune Activation. Trends Neurosci. 2019;42(11):793\u2013806.","journal-title":"Trends Neurosci"},{"issue":"6276","key":"8395_CR17","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1126\/science.aad0314","volume":"351","author":"GB Choi","year":"2016","unstructured":"Choi GB, et al. The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science. 2016;351(6276):933\u20139.","journal-title":"Science"},{"key":"8395_CR18","doi-asserted-by":"publisher","first-page":"1348092","DOI":"10.3389\/fpsyt.2024.1348092","volume":"15","author":"J McLellan","year":"2024","unstructured":"McLellan J, et al. Altered cytokine and chemokine profile linked to autoantibody and pathogen reactivity in mothers of autistic children. Front Psychiatry. 2024;15:1348092.","journal-title":"Front Psychiatry"},{"issue":"7","key":"8395_CR19","doi-asserted-by":"publisher","first-page":"e277","DOI":"10.1038\/tp.2013.50","volume":"3","author":"D Braunschweig","year":"2013","unstructured":"Braunschweig D, et al. Autism-specific maternal autoantibodies recognize critical proteins in developing brain. Transl Psychiatry. 2013;3(7):e277.","journal-title":"Transl Psychiatry"},{"issue":"11","key":"8395_CR20","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/mp.2013.101","volume":"18","author":"L Brimberg","year":"2013","unstructured":"Brimberg L, et al. Brain-reactive IgG correlates with autoimmunity in mothers of a child with an autism spectrum disorder. Mol Psychiatry. 2013;18(11):1171\u20137.","journal-title":"Mol Psychiatry"},{"issue":"12","key":"8395_CR21","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1080\/15592294.2015.1114202","volume":"10","author":"MA Labouesse","year":"2015","unstructured":"Labouesse MA, et al. Maternal immune activation induces GAD1 and GAD2 promoter remodeling in the offspring prefrontal cortex. Epigenetics. 2015;10(12):1143\u201355.","journal-title":"Epigenetics"},{"issue":"4","key":"8395_CR22","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s40489-015-0059-4","volume":"2","author":"C Miyazaki","year":"2015","unstructured":"Miyazaki C, et al. Allergies in Children with Autism Spectrum Disorder: a Systematic Review and Meta-analysis. Rev J Autism Dev Disorders. 2015;2(4):374\u2013401.","journal-title":"Rev J Autism Dev Disorders"},{"issue":"6","key":"8395_CR23","doi-asserted-by":"publisher","first-page":"e0156662","DOI":"10.1371\/journal.pone.0156662","volume":"11","author":"Z Zheng","year":"2016","unstructured":"Zheng Z, et al. Association between Asthma and Autism Spectrum Disorder: A Meta-Analysis. PLoS ONE. 2016;11(6):e0156662.","journal-title":"PLoS ONE"},{"issue":"1","key":"8395_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/aur.1854","volume":"11","author":"C Holingue","year":"2018","unstructured":"Holingue C, et al. Gastrointestinal symptoms in autism spectrum disorder: A review of the literature on ascertainment and prevalence. Autism Res. 2018;11(1):24\u201336.","journal-title":"Autism Res"},{"key":"8395_CR25","doi-asserted-by":"publisher","first-page":"100042","DOI":"10.1016\/j.bbih.2020.100042","volume":"2","author":"DR Rose","year":"2020","unstructured":"Rose DR, et al. T cell populations in children with autism spectrum disorder and co-morbid gastrointestinal symptoms. Brain Behav Immun Health. 2020;2:100042.","journal-title":"Brain Behav Immun Health"},{"issue":"1","key":"8395_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13229-021-00472-4","volume":"12","author":"P Ellul","year":"2021","unstructured":"Ellul P, et al. Regulatory T lymphocytes\/Th17 lymphocytes imbalance in autism spectrum disorders: evidence from a meta-analysis. Mol Autism. 2021;12(1):68.","journal-title":"Mol Autism"},{"issue":"1","key":"8395_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41398-023-02335-3","volume":"13","author":"C Bagnall-Moreau","year":"2023","unstructured":"Bagnall-Moreau C, Spielman B, Brimberg L. Maternal brain reactive antibodies profile in autism spectrum disorder: an update. Transl Psychiatry. 2023;13(1):37.","journal-title":"Transl Psychiatry"},{"issue":"1","key":"8395_CR28","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/npp.2016.158","volume":"42","author":"A Meltzer","year":"2017","unstructured":"Meltzer A, Van de Water J. The Role of the Immune System in Autism Spectrum Disorder. Neuropsychopharmacology. 2017;42(1):284\u201398.","journal-title":"Neuropsychopharmacology"},{"key":"8395_CR29","doi-asserted-by":"publisher","first-page":"879021","DOI":"10.3389\/fnagi.2022.879021","volume":"14","author":"HM Blevins","year":"2022","unstructured":"Blevins HM, et al. The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases. Front Aging Neurosci. 2022;14:879021.","journal-title":"Front Aging Neurosci"},{"key":"8395_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.mito.2019.12.005","volume":"51","author":"RK Naviaux","year":"2020","unstructured":"Naviaux RK. Perspective: Cell danger response Biology-The new science that connects environmental health with mitochondria and the rising tide of chronic illness. Mitochondrion. 2020;51:40\u20135.","journal-title":"Mitochondrion"},{"key":"8395_CR31","doi-asserted-by":"crossref","unstructured":"Naviaux RK. The 3-Hit Metabolic signaling model for autism spectrum disorder: a summary. Autism Res. 2026:e70228.","DOI":"10.1002\/aur.70228"},{"issue":"7","key":"8395_CR32","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2016.58","volume":"16","author":"P Broz","year":"2016","unstructured":"Broz P, Dixit VM. Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol. 2016;16(7):407\u201320.","journal-title":"Nat Rev Immunol"},{"issue":"47","key":"8395_CR33","doi-asserted-by":"publisher","first-page":"82390","DOI":"10.18632\/oncotarget.19326","volume":"8","author":"J Xie","year":"2017","unstructured":"Xie J, et al. Immunological cytokine profiling identifies TNF-alpha as a key molecule dysregulated in autistic children. Oncotarget. 2017;8(47):82390\u20138.","journal-title":"Oncotarget"},{"key":"8395_CR34","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.cyto.2018.03.034","volume":"108","author":"MM Eftekharian","year":"2018","unstructured":"Eftekharian MM, et al. Cytokine profile in autistic patients. Cytokine. 2018;108:120\u20136.","journal-title":"Cytokine"},{"issue":"6","key":"8395_CR35","doi-asserted-by":"publisher","first-page":"e39049","DOI":"10.1371\/journal.pone.0039049","volume":"7","author":"AM Young","year":"2012","unstructured":"Young AM, et al. Regional susceptibility to TNF-alpha induction of murine brain inflammation via classical IKK\/NF-kappaB signalling. PLoS ONE. 2012;7(6):e39049.","journal-title":"PLoS ONE"},{"issue":"4","key":"8395_CR36","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1017\/neu.2019.18","volume":"31","author":"N Strenn","year":"2019","unstructured":"Strenn N, et al. Associations between autistic-like traits and polymorphisms in NFKBIL1. Acta Neuropsychiatr. 2019;31(4):220\u20139.","journal-title":"Acta Neuropsychiatr"},{"key":"8395_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fpsyt.2011.00027","volume":"2","author":"AM Young","year":"2011","unstructured":"Young AM, et al. Aberrant NF-kappaB expression in autism spectrum condition: a mechanism for neuroinflammation. Front Psychiatry. 2011;2:27.","journal-title":"Front Psychiatry"},{"key":"8395_CR38","doi-asserted-by":"publisher","first-page":"785265","DOI":"10.1155\/2011\/785265","volume":"2011","author":"M Malik","year":"2011","unstructured":"Malik M, et al. NF-kappaB signaling in the brain of autistic subjects. Mediators Inflamm. 2011;2011:785265.","journal-title":"Mediators Inflamm"},{"issue":"1","key":"8395_CR39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/ana.20315","volume":"57","author":"DL Vargas","year":"2005","unstructured":"Vargas DL, et al. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol. 2005;57(1):67\u201381.","journal-title":"Ann Neurol"},{"issue":"3","key":"8395_CR40","doi-asserted-by":"publisher","first-page":"319","DOI":"10.31887\/DCNS.2012.14.3\/gdichter","volume":"14","author":"GS Dichter","year":"2012","unstructured":"Dichter GS. Functional magnetic resonance imaging of autism spectrum disorders. Dialogues Clin Neurosci. 2012;14(3):319\u201351.","journal-title":"Dialogues Clin Neurosci"},{"issue":"1","key":"8395_CR41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12993-021-00185-x","volume":"17","author":"D Sun","year":"2021","unstructured":"Sun D, et al. NLRP1 inflammasome involves in learning and memory impairments and neuronal damages during aging process in mice. Behav Brain Funct. 2021;17(1):11.","journal-title":"Behav Brain Funct"},{"issue":"4","key":"8395_CR42","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/glia.22454","volume":"61","author":"Y Jamilloux","year":"2013","unstructured":"Jamilloux Y, et al. Inflammasome activation restricts Legionella pneumophila replication in primary microglial cells through flagellin detection. Glia. 2013;61(4):539\u201349.","journal-title":"Glia"},{"key":"8395_CR43","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.bbi.2016.03.009","volume":"57","author":"M Saresella","year":"2016","unstructured":"Saresella M, et al. Multiple inflammasome complexes are activated in autistic spectrum disorders. Brain Behav Immun. 2016;57:125\u201333.","journal-title":"Brain Behav Immun"},{"issue":"2","key":"8395_CR44","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1006\/geno.1994.1517","volume":"23","author":"K Sugaya","year":"1994","unstructured":"Sugaya K, et al. Three genes in the human MHC class III region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3. Genomics. 1994;23(2):408\u201319.","journal-title":"Genomics"},{"issue":"1","key":"8395_CR45","doi-asserted-by":"publisher","first-page":"e86903","DOI":"10.1371\/journal.pone.0086903","volume":"9","author":"L Sessa","year":"2014","unstructured":"Sessa L, et al. The receptor for advanced glycation end-products (RAGE) is only present in mammals, and belongs to a family of cell adhesion molecules (CAMs). PLoS ONE. 2014;9(1):e86903.","journal-title":"PLoS ONE"},{"key":"8395_CR46","doi-asserted-by":"publisher","first-page":"931473","DOI":"10.3389\/fimmu.2022.931473","volume":"13","author":"H Dong","year":"2022","unstructured":"Dong H, et al. Pathophysiology of RAGE in inflammatory diseases. Front Immunol. 2022;13:931473.","journal-title":"Front Immunol"},{"issue":"51","key":"8395_CR47","doi-asserted-by":"publisher","first-page":"35507","DOI":"10.1074\/jbc.M806948200","volume":"283","author":"L Zhang","year":"2008","unstructured":"Zhang L, et al. Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases. J Biol Chem. 2008;283(51):35507\u201316.","journal-title":"J Biol Chem"},{"key":"8395_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vph.2015.06.011","volume":"72","author":"AM Schmidt","year":"2015","unstructured":"Schmidt AM. Soluble RAGEs - Prospects for treating & tracking metabolic and inflammatory disease. Vascul Pharmacol. 2015;72:1\u20138.","journal-title":"Vascul Pharmacol"},{"key":"8395_CR49","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.redox.2013.12.016","volume":"2","author":"C Ott","year":"2014","unstructured":"Ott C, et al. Role of advanced glycation end products in cellular signaling. Redox Biol. 2014;2:411\u201329.","journal-title":"Redox Biol"},{"key":"8395_CR50","doi-asserted-by":"crossref","unstructured":"Wetzels S, et al. Methylglyoxal-derived advanced glycation endproducts in multiple sclerosis. Int J Mol Sci. 2017;18(2).","DOI":"10.3390\/ijms18020421"},{"key":"8395_CR51","doi-asserted-by":"publisher","first-page":"1128872","DOI":"10.3389\/fphar.2023.1128872","volume":"14","author":"K Taguchi","year":"2023","unstructured":"Taguchi K, Fukami K. RAGE signaling regulates the progression of diabetic complications. Front Pharmacol. 2023;14:1128872.","journal-title":"Front Pharmacol"},{"issue":"6","key":"8395_CR52","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.2337\/db13-1636","volume":"63","author":"F Song","year":"2014","unstructured":"Song F, et al. RAGE regulates the metabolic and inflammatory response to high-fat feeding in mice. Diabetes. 2014;63(6):1948\u201365.","journal-title":"Diabetes"},{"key":"8395_CR53","doi-asserted-by":"publisher","first-page":"102701","DOI":"10.1016\/j.dnarep.2019.102701","volume":"83","author":"P Mandke","year":"2019","unstructured":"Mandke P, Vasquez KM. Interactions of high mobility group box protein 1 (HMGB1) with nucleic acids: Implications in DNA repair and immune responses. DNA Repair (Amst). 2019;83:102701.","journal-title":"DNA Repair (Amst)"},{"key":"8395_CR54","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.3389\/fimmu.2017.01908","volume":"8","author":"C Xia","year":"2017","unstructured":"Xia C, et al. S100 Proteins As an Important Regulator of Macrophage Inflammation. Front Immunol. 2017;8:1908.","journal-title":"Front Immunol"},{"issue":"7","key":"8395_CR55","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/nm890","volume":"9","author":"R Deane","year":"2003","unstructured":"Deane R, et al. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med. 2003;9(7):907\u201313.","journal-title":"Nat Med"},{"issue":"1","key":"8395_CR56","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s42003-020-0799-2","volume":"3","author":"Y Yamamoto","year":"2020","unstructured":"Yamamoto Y, Higashida H. RAGE regulates oxytocin transport into the brain. Commun Biology. 2020;3(1):70.","journal-title":"Commun Biology"},{"issue":"10","key":"8395_CR57","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1084\/jem.20030800","volume":"198","author":"T Chavakis","year":"2003","unstructured":"Chavakis T, et al. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med. 2003;198(10):1507\u201315.","journal-title":"J Exp Med"},{"issue":"4","key":"8395_CR58","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/embor.2011.28","volume":"12","author":"M He","year":"2011","unstructured":"He M, et al. Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells. EMBO Rep. 2011;12(4):358\u201364.","journal-title":"EMBO Rep"},{"issue":"6","key":"8395_CR59","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/S2213-8587(25)00036-1","volume":"13","author":"W Ye","year":"2025","unstructured":"Ye W, et al. Association between maternal diabetes and neurodevelopmental outcomes in children: a systematic review and meta-analysis of 202 observational studies comprising 56.1 million pregnancies. Lancet Diabetes Endocrinol. 2025;13(6):494\u2013504.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"8395_CR60","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jpsychires.2025.01.003","volume":"182","author":"MJ Garza-Martinez","year":"2025","unstructured":"Garza-Martinez MJ, et al. Maternal diabetes during pregnancy and offspring\u2019s risk of autism spectrum disorder: A systematic review and meta-analysis. J Psychiatr Res. 2025;182:100\u201315.","journal-title":"J Psychiatr Res"},{"issue":"6","key":"8395_CR61","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.2337\/db12-1528","volume":"62","author":"E Selvin","year":"2013","unstructured":"Selvin E, et al. sRAGE and risk of diabetes, cardiovascular disease, and death. Diabetes. 2013;62(6):2116\u201321.","journal-title":"Diabetes"},{"issue":"1","key":"8395_CR62","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12902-024-01759-2","volume":"24","author":"Q Chen","year":"2024","unstructured":"Chen Q, et al. Association between the soluble receptor for advanced glycation end products and diabetes mellitus: systematic review and meta-analysis. BMC Endocr Disord. 2024;24(1):232.","journal-title":"BMC Endocr Disord"},{"key":"8395_CR63","doi-asserted-by":"publisher","first-page":"34248","DOI":"10.1038\/srep34248","volume":"6","author":"Y Wang","year":"2016","unstructured":"Wang Y, et al. Maternal Body Mass Index and Risk of Autism Spectrum Disorders in Offspring: A Meta-analysis. Sci Rep. 2016;6:34248.","journal-title":"Sci Rep"},{"issue":"2","key":"8395_CR64","doi-asserted-by":"publisher","first-page":"e1920787","DOI":"10.1001\/jamanetworkopen.2019.20787","volume":"3","author":"L Kong","year":"2020","unstructured":"Kong L, et al. Associations of Different Types of Maternal Diabetes and Body Mass Index With Offspring Psychiatric Disorders. JAMA Netw Open. 2020;3(2):e1920787.","journal-title":"JAMA Netw Open"},{"key":"8395_CR65","doi-asserted-by":"crossref","unstructured":"Palmer IL, et al. RAGE knockout mitigates diet-induced obesity and metabolic disruption. Metabolites. 2025;15(8).","DOI":"10.3390\/metabo15080524"},{"key":"8395_CR66","unstructured":"Kanikowska D, et al. Soluble receptor for advanced glycation end products (sRAGE) correlates with obesity-related parameters, and it is not easy to be modified by moderate caloric restriction in obese humans. J Physiol Pharmacol. 2022;73(4)."},{"issue":"3","key":"8395_CR67","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1192\/bjp.2017.27","volume":"212","author":"BA Dachew","year":"2018","unstructured":"Dachew BA, et al. Pre-eclampsia and the risk of autism-spectrum disorder in offspring: meta-analysis. Br J Psychiatry. 2018;212(3):142\u20137.","journal-title":"Br J Psychiatry"},{"issue":"9","key":"8395_CR68","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1097\/01.hjh.0000177535.45785.64","volume":"23","author":"D Geroldi","year":"2005","unstructured":"Geroldi D, et al. Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension. J Hypertens. 2005;23(9):1725\u20139.","journal-title":"J Hypertens"},{"issue":"5","key":"8395_CR69","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1515\/jpm.2011.055","volume":"39","author":"JH Kwon","year":"2011","unstructured":"Kwon JH, et al. Clinical significance of serum sRAGE and esRAGE in women with normal pregnancy and preeclampsia. J Perinat Med. 2011;39(5):507\u201313.","journal-title":"J Perinat Med"},{"key":"8395_CR70","doi-asserted-by":"publisher","first-page":"1587699","DOI":"10.3389\/frph.2025.1587699","volume":"7","author":"N Chandra","year":"2025","unstructured":"Chandra N, et al. Inflammatory mediators and the RAGE pathway in placental tissues of pregnancies complicated by severe preeclampsia. Front Reprod Health. 2025;7:1587699.","journal-title":"Front Reprod Health"},{"key":"8395_CR71","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13229-017-0183-3","volume":"9","author":"A Anwar","year":"2018","unstructured":"Anwar A, et al. Advanced glycation endproducts, dityrosine and arginine transporter dysfunction in autism - a source of biomarkers for clinical diagnosis. Mol Autism. 2018;9:3.","journal-title":"Mol Autism"},{"issue":"3","key":"8395_CR72","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.neulet.2006.08.092","volume":"410","author":"M Boso","year":"2006","unstructured":"Boso M, et al. Alterations of circulating endogenous secretory RAGE and S100A9 levels indicating dysfunction of the AGE-RAGE axis in autism. Neurosci Lett. 2006;410(3):169\u201373.","journal-title":"Neurosci Lett"},{"key":"8395_CR73","doi-asserted-by":"crossref","unstructured":"Makris G, et al. Increased serum concentrations of high mobility group box 1 (HMGB1) protein in children with autism spectrum disorder. Children (Basel). 2021;8(6).","DOI":"10.3390\/children8060478"},{"issue":"8","key":"8395_CR74","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1007\/s10803-020-04710-1","volume":"51","author":"Z Zheng","year":"2021","unstructured":"Zheng Z, Zheng P, Zou X. Peripheral Blood S100B Levels in Autism Spectrum Disorder: A Systematic Review and Meta-Analysis. J Autism Dev Disord. 2021;51(8):2569\u201377.","journal-title":"J Autism Dev Disord"},{"issue":"3","key":"8395_CR75","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/sj.mp.4001943","volume":"12","author":"BA Corbett","year":"2007","unstructured":"Corbett BA, et al. A proteomic study of serum from children with autism showing differential expression of apolipoproteins and complement proteins. Mol Psychiatry. 2007;12(3):292\u2013306.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"8395_CR76","first-page":"19","volume":"3","author":"K Fagan","year":"2017","unstructured":"Fagan K, et al. Complement C3 Expression Is Decreased in Autism Spectrum Disorder Subjects and Contributes to Behavioral Deficits in Rodents. Mol Neuropsychiatry. 2017;3(1):19\u201327.","journal-title":"Mol Neuropsychiatry"},{"key":"8395_CR77","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2147\/ITT.S305420","volume":"10","author":"A Gomez-Arboledas","year":"2021","unstructured":"Gomez-Arboledas A, Acharya MM, Tenner AJ. The Role of Complement in Synaptic Pruning and Neurodegeneration. Immunotargets Ther. 2021;10:373\u201386.","journal-title":"Immunotargets Ther"},{"key":"8395_CR78","doi-asserted-by":"publisher","first-page":"809543","DOI":"10.3389\/fpsyt.2022.809543","volume":"13","author":"X Li","year":"2022","unstructured":"Li X, et al. Regressive Autism Spectrum Disorder: High Levels of Total Secreted Amyloid Precursor Protein and Secreted Amyloid Precursor Protein-alpha in Plasma. Front Psychiatry. 2022;13:809543.","journal-title":"Front Psychiatry"},{"issue":"6","key":"8395_CR79","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1093\/hmg\/ddy017","volume":"27","author":"F Fang","year":"2018","unstructured":"Fang F, et al. RAGE mediates Abeta accumulation in a mouse model of Alzheimer\u2019s disease via modulation of beta- and gamma-secretase activity. Hum Mol Genet. 2018;27(6):1002\u201314.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"8395_CR80","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.biopsych.2015.08.008","volume":"79","author":"R Feldman","year":"2016","unstructured":"Feldman R, et al. Oxytocin Pathway Genes: Evolutionary Ancient System Impacting on Human Affiliation, Sociality, and Psychopathology. Biol Psychiatry. 2016;79(3):174\u201384.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"8395_CR81","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41398-018-0315-3","volume":"8","author":"SM Freeman","year":"2018","unstructured":"Freeman SM, et al. Effect of age and autism spectrum disorder on oxytocin receptor density in the human basal forebrain and midbrain. Transl Psychiatry. 2018;8(1):257.","journal-title":"Transl Psychiatry"},{"issue":"8","key":"8395_CR82","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41386-022-01305-5","volume":"47","author":"J Rokicki","year":"2022","unstructured":"Rokicki J, et al. Oxytocin receptor expression patterns in the human brain across development. Neuropsychopharmacology. 2022;47(8):1550\u201360.","journal-title":"Neuropsychopharmacology"},{"issue":"5806","key":"8395_CR83","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1126\/science.1133212","volume":"314","author":"R Tyzio","year":"2006","unstructured":"Tyzio R, et al. Maternal oxytocin triggers a transient inhibitory switch in GABA signaling in the fetal brain during delivery. Science. 2006;314(5806):1788\u201392.","journal-title":"Science"},{"issue":"1","key":"8395_CR84","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11011-026-01791-2","volume":"41","author":"A El-Ansary","year":"2026","unstructured":"El-Ansary A, et al. Plasma KCC2, NKCC1, and GABA as peripheral biomarkers in autism spectrum disorder: a combined ROC analysis. Metab Brain Dis. 2026;41(1):29.","journal-title":"Metab Brain Dis"},{"issue":"5","key":"8395_CR85","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/mp.2014.77","volume":"20","author":"D LoParo","year":"2015","unstructured":"LoParo D, Waldman ID. The oxytocin receptor gene (OXTR) is associated with autism spectrum disorder: a meta-analysis. Mol Psychiatry. 2015;20(5):640\u20136.","journal-title":"Mol Psychiatry"},{"issue":"4","key":"8395_CR86","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3390\/brainsci13040689","volume":"13","author":"KM Wilczy\u0144ski","year":"2023","unstructured":"Wilczy\u0144ski KM, et al. Polymorphisms in Oxytocin and Vasopressin Receptor Genes as a Factor Shaping the Clinical Picture and the Risk of ASD in Males. Brain Sci. 2023;13(4):689.","journal-title":"Brain Sci"},{"key":"8395_CR87","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neubiorev.2020.12.028","volume":"122","author":"Y Huang","year":"2021","unstructured":"Huang Y, et al. Intranasal oxytocin in the treatment of autism spectrum disorders: A multilevel meta-analysis. Neurosci Biobehav Rev. 2021;122:18\u201327.","journal-title":"Neurosci Biobehav Rev"},{"issue":"8","key":"8395_CR88","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1177\/13623613211034375","volume":"25","author":"S John","year":"2021","unstructured":"John S, Jaeggi AV. Oxytocin levels tend to be lower in autistic children: A meta-analysis of 31 studies. Autism. 2021;25(8):2152\u201361.","journal-title":"Autism"},{"issue":"33","key":"8395_CR89","doi-asserted-by":"publisher","first-page":"12258","DOI":"10.1073\/pnas.1402236111","volume":"111","author":"KJ Parker","year":"2014","unstructured":"Parker KJ, et al. Plasma oxytocin concentrations and OXTR polymorphisms predict social impairments in children with and without autism spectrum disorder. Proc Natl Acad Sci U S A. 2014;111(33):12258\u201363.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"8395_CR90","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1007\/s00228-023-03545-w","volume":"79","author":"L Hu","year":"2023","unstructured":"Hu L, et al. Oxytocin treatment for core symptoms in children with autism spectrum disorder: a systematic review and meta-analysis. Eur J Clin Pharmacol. 2023;79(10):1357\u201363.","journal-title":"Eur J Clin Pharmacol"},{"issue":"16","key":"8395_CR91","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1056\/NEJMoa2103583","volume":"385","author":"L Sikich","year":"2021","unstructured":"Sikich L, et al. Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder. N Engl J Med. 2021;385(16):1462\u201373.","journal-title":"N Engl J Med"},{"issue":"7","key":"8395_CR92","doi-asserted-by":"publisher","first-page":"e0132224","DOI":"10.1371\/journal.pone.0132224","volume":"10","author":"DS Carson","year":"2015","unstructured":"Carson DS, et al. Arginine Vasopressin Is a Blood-Based Biomarker of Social Functioning in Children with Autism. PLoS ONE. 2015;10(7):e0132224.","journal-title":"PLoS ONE"},{"key":"8395_CR93","doi-asserted-by":"crossref","unstructured":"Parker KJ, et al. A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism. Sci Transl Med. 2019;11(491).","DOI":"10.1126\/scitranslmed.aau7356"},{"issue":"7","key":"8395_CR94","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.cell.2013.11.024","volume":"155","author":"EY Hsiao","year":"2013","unstructured":"Hsiao EY, et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell. 2013;155(7):1451\u201363.","journal-title":"Cell"},{"issue":"7","key":"8395_CR95","doi-asserted-by":"publisher","first-page":"e68322","DOI":"10.1371\/journal.pone.0068322","volume":"8","author":"DW Kang","year":"2013","unstructured":"Kang DW, et al. Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS ONE. 2013;8(7):e68322.","journal-title":"PLoS ONE"},{"issue":"3\u20134","key":"8395_CR96","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s11046-016-0068-6","volume":"182","author":"MR Iovene","year":"2017","unstructured":"Iovene MR, et al. Intestinal Dysbiosis and Yeast Isolation in Stool of Subjects with Autism Spectrum Disorders. Mycopathologia. 2017;182(3\u20134):349\u201363.","journal-title":"Mycopathologia"},{"key":"8395_CR97","doi-asserted-by":"publisher","first-page":"635925","DOI":"10.3389\/fnins.2021.635925","volume":"15","author":"X Cao","year":"2021","unstructured":"Cao X, et al. Dysbiotic Gut Microbiota and Dysregulation of Cytokine Profile in Children and Teens With Autism Spectrum Disorder. Front Neurosci. 2021;15:635925.","journal-title":"Front Neurosci"},{"key":"8395_CR98","doi-asserted-by":"crossref","unstructured":"Danhof HA, et al. Microbial stimulation of oxytocin release from the intestinal epithelium via secretin signaling. bioRxiv. 2023.","DOI":"10.1101\/2023.03.09.531917"},{"key":"8395_CR99","doi-asserted-by":"publisher","first-page":"721884","DOI":"10.3389\/fnins.2021.721884","volume":"15","author":"M Huang","year":"2021","unstructured":"Huang M, et al. Serum Oxytocin Level Correlates With Gut Microbiome Dysbiosis in Children With Autism Spectrum Disorder. Front Neurosci. 2021;15:721884.","journal-title":"Front Neurosci"},{"issue":"24","key":"8395_CR100","doi-asserted-by":"publisher","first-page":"5916","DOI":"10.1016\/j.cell.2021.10.015","volume":"184","author":"CX Yap","year":"2021","unstructured":"Yap CX, et al. Autism-related dietary preferences mediate autism-gut microbiome associations. Cell. 2021;184(24):5916\u2013e593117.","journal-title":"Cell"},{"key":"8395_CR101","doi-asserted-by":"crossref","unstructured":"Khan I, et al. Alteration of gut microbiota in inflammatory bowel disease (ibd): cause or consequence? IBD treatment targeting the gut microbiome. Pathogens. 2019;8(3).","DOI":"10.3390\/pathogens8030126"},{"issue":"1","key":"8395_CR102","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41598-018-36430-z","volume":"9","author":"S Liu","year":"2019","unstructured":"Liu S, et al. Altered gut microbiota and short chain fatty acids in Chinese children with autism spectrum disorder. Sci Rep. 2019;9(1):287.","journal-title":"Sci Rep"},{"key":"8395_CR103","doi-asserted-by":"crossref","unstructured":"Macfabe DF. Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders. Microb Ecol Health Dis. 2012;23.","DOI":"10.3402\/mehd.v23i0.19260"},{"key":"8395_CR104","doi-asserted-by":"crossref","unstructured":"Grimaldi R, et al. In vitro fermentation of B-GOS: impact on faecal bacterial populations and metabolic activity in autistic and non-autistic children. FEMS Microbiol Ecol. 2017;93(2).","DOI":"10.1093\/femsec\/fiw233"},{"issue":"8","key":"8395_CR105","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1007\/s10620-012-2167-7","volume":"57","author":"L Wang","year":"2012","unstructured":"Wang L, et al. Elevated fecal short chain fatty acid and ammonia concentrations in children with autism spectrum disorder. Dig Dis Sci. 2012;57(8):2096\u2013102.","journal-title":"Dig Dis Sci"},{"key":"8395_CR106","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13229-016-0109-5","volume":"7","author":"F Gevi","year":"2016","unstructured":"Gevi F, et al. Urinary metabolomics of young Italian autistic children supports abnormal tryptophan and purine metabolism. Mol Autism. 2016;7:47.","journal-title":"Mol Autism"},{"key":"8395_CR107","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neuroscience.2015.11.010","volume":"321","author":"CL Muller","year":"2016","unstructured":"Muller CL, Anacker AMJ, Veenstra-VanderWeele J. The serotonin system in autism spectrum disorder: From biomarker to animal models. Neuroscience. 2016;321:24\u201341.","journal-title":"Neuroscience"},{"key":"8395_CR108","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3389\/fneur.2019.00778","volume":"10","author":"GD Colpo","year":"2019","unstructured":"Colpo GD, et al. Systematic Review on the Involvement of the Kynurenine Pathway in Stroke: Pre-clinical and Clinical Evidence. Front Neurol. 2019;10:778.","journal-title":"Front Neurol"},{"issue":"2","key":"8395_CR109","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jtcme.2022.03.001","volume":"13","author":"A Mehra","year":"2023","unstructured":"Mehra A, et al. Gut microbiota and Autism Spectrum Disorder: From pathogenesis to potential therapeutic perspectives. J Tradit Complement Med. 2023;13(2):135\u201349.","journal-title":"J Tradit Complement Med"},{"issue":"1","key":"8395_CR110","doi-asserted-by":"publisher","first-page":"e0258023","DOI":"10.1128\/spectrum.02580-23","volume":"12","author":"H Tames","year":"2024","unstructured":"Tames H, et al. Mouse intestinal microbiome modulation by oral administration of a GABA-producing Bifidobacterium adolescentis strain. Microbiol Spectr. 2024;12(1):e0258023.","journal-title":"Microbiol Spectr"},{"issue":"38","key":"8395_CR111","doi-asserted-by":"publisher","first-page":"16050","DOI":"10.1073\/pnas.1102999108","volume":"108","author":"JA Bravo","year":"2011","unstructured":"Bravo JA, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A. 2011;108(38):16050\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"8395_CR112","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1021\/acs.jafc.3c07260","volume":"72","author":"H Kim","year":"2024","unstructured":"Kim H, et al. Lactobacillus brevis-Fermented Gamma-Aminobutyric Acid Ameliorates Depression- and Anxiety-Like Behaviors by Activating the Brain-Derived Neurotrophic Factor-Tropomyosin Receptor Kinase B Signaling Pathway in BALB\/C Mice. J Agric Food Chem. 2024;72(6):2977\u201388.","journal-title":"J Agric Food Chem"},{"issue":"2","key":"8395_CR113","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1159\/000518385","volume":"81","author":"V Nobile","year":"2022","unstructured":"Nobile V, Giardina S, Puoci F. The Effect of a Probiotic Complex on the Gut-Brain Axis: A Translational Study. Neuropsychobiology. 2022;81(2):116\u201326.","journal-title":"Neuropsychobiology"},{"key":"8395_CR114","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.bbi.2018.05.015","volume":"73","author":"L Tabouy","year":"2018","unstructured":"Tabouy L, et al. Dysbiosis of microbiome and probiotic treatment in a genetic model of autism spectrum disorders. Brain Behav Immun. 2018;73:310\u20139.","journal-title":"Brain Behav Immun"},{"key":"8395_CR115","doi-asserted-by":"crossref","unstructured":"Zheng Y, et al. The autism spectrum disorder-associated bacterial metabolite p-cresol derails the neuroimmune response of microglial cells partially via reduction of ADAM17 and ADAM10. Int J Mol Sci. 2022;23(19).","DOI":"10.3390\/ijms231911013"},{"key":"8395_CR116","doi-asserted-by":"crossref","unstructured":"Pascucci T, et al. P-cresol alters brain dopamine metabolism and exacerbates autism-like behaviors in the BTBR mouse. Brain Sci. 2020;10(4).","DOI":"10.3390\/brainsci10040233"},{"issue":"1","key":"8395_CR117","doi-asserted-by":"publisher","first-page":"6547","DOI":"10.1038\/s41598-023-32798-9","volume":"13","author":"H Jung","year":"2023","unstructured":"Jung H, et al. LPS induces microglial activation and GABAergic synaptic deficits in the hippocampus accompanied by prolonged cognitive impairment. Sci Rep. 2023;13(1):6547.","journal-title":"Sci Rep"},{"key":"8395_CR118","doi-asserted-by":"publisher","first-page":"634837","DOI":"10.3389\/fcell.2021.634837","volume":"9","author":"L Xiao","year":"2021","unstructured":"Xiao L, et al. Critical Role of TLR4 on the Microglia Activation Induced by Maternal LPS Exposure Leading to ASD-Like Behavior of Offspring. Front Cell Dev Biol. 2021;9:634837.","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"8395_CR119","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/nm.4397","volume":"23","author":"MW Salter","year":"2017","unstructured":"Salter MW, Stevens B. Microglia emerge as central players in brain disease. Nat Med. 2017;23(9):1018\u201327.","journal-title":"Nat Med"},{"issue":"4","key":"8395_CR120","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s11481-009-9170-6","volume":"4","author":"MM Mariani","year":"2009","unstructured":"Mariani MM, Kielian T. Microglia in infectious diseases of the central nervous system. J Neuroimmune Pharmacol. 2009;4(4):448\u201361.","journal-title":"J Neuroimmune Pharmacol"},{"key":"8395_CR121","doi-asserted-by":"crossref","unstructured":"Andoh M, Koyama R. Comparative review of microglia and monocytes in CNS phagocytosis. Cells. 2021;10(10).","DOI":"10.3390\/cells10102555"},{"key":"8395_CR122","doi-asserted-by":"crossref","unstructured":"Planas AM. Role of microglia in stroke. Glia. 2024.","DOI":"10.1002\/glia.24501"},{"key":"8395_CR123","doi-asserted-by":"publisher","first-page":"1305933","DOI":"10.3389\/fimmu.2023.1305933","volume":"14","author":"L Fornari Laurindo","year":"2023","unstructured":"Fornari Laurindo L, et al. Immunological dimensions of neuroinflammation and microglial activation: exploring innovative immunomodulatory approaches to mitigate neuroinflammatory progression. Front Immunol. 2023;14:1305933.","journal-title":"Front Immunol"},{"key":"8395_CR124","doi-asserted-by":"crossref","unstructured":"Luo Y, Wang Z. The impact of microglia on neurodevelopment and brain function in Autism. Biomedicines. 2024;12(1).","DOI":"10.3390\/biomedicines12010210"},{"issue":"6","key":"8395_CR125","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1007\/s10803-022-05535-w","volume":"53","author":"G Li","year":"2023","unstructured":"Li G, et al. Volumetric Analysis of Amygdala and Hippocampal Subfields for Infants with Autism. J Autism Dev Disord. 2023;53(6):2475\u201389.","journal-title":"J Autism Dev Disord"},{"issue":"6","key":"8395_CR126","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41582-019-0186-0","volume":"15","author":"S Lempriere","year":"2019","unstructured":"Lempriere S. Autism mutation produces hyper-connected neurons. Nat Rev Neurol. 2019;15(6):308\u20139.","journal-title":"Nat Rev Neurol"},{"issue":"10\u201312","key":"8395_CR127","first-page":"40","volume":"20","author":"LT Ong","year":"2023","unstructured":"Ong LT, Fan SWD. Morphological and Functional Changes of Cerebral Cortex in Autism Spectrum Disorder. Innov Clin Neurosci. 2023;20(10\u201312):40\u20137.","journal-title":"Innov Clin Neurosci"},{"key":"8395_CR128","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/neuro.04.004.2008","volume":"2","author":"T Rinaldi","year":"2008","unstructured":"Rinaldi T, Perrodin C, Markram H. Hyper-connectivity and hyper-plasticity in the medial prefrontal cortex in the valproic Acid animal model of autism. Front Neural Circuits. 2008;2:4.","journal-title":"Front Neural Circuits"},{"issue":"6","key":"8395_CR129","doi-asserted-by":"publisher","first-page":"148","DOI":"10.31083\/j.jin2206148","volume":"22","author":"G Cavaliere","year":"2023","unstructured":"Cavaliere G, Traina G. Neuroinflammation in the Brain and Role of Intestinal Microbiota: An Overview of the Players. J Integr Neurosci. 2023;22(6):148.","journal-title":"J Integr Neurosci"},{"key":"8395_CR130","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bbi.2019.04.037","volume":"79","author":"SM Matta","year":"2019","unstructured":"Matta SM, Hill-Yardin EL, Crack PJ. The influence of neuroinflammation in Autism Spectrum Disorder. Brain Behav Immun. 2019;79:75\u201390.","journal-title":"Brain Behav Immun"},{"issue":"3","key":"8395_CR131","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.neulet.2010.01.033","volume":"471","author":"E Emanuele","year":"2010","unstructured":"Emanuele E, et al. Low-grade endotoxemia in patients with severe autism. Neurosci Lett. 2010;471(3):162\u20135.","journal-title":"Neurosci Lett"},{"issue":"1","key":"8395_CR132","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12974-016-0541-7","volume":"13","author":"L Yuan","year":"2016","unstructured":"Yuan L, et al. Oxytocin inhibits lipopolysaccharide-induced inflammation in microglial cells and attenuates microglial activation in lipopolysaccharide-treated mice. J Neuroinflammation. 2016;13(1):77.","journal-title":"J Neuroinflammation"},{"key":"8395_CR133","doi-asserted-by":"publisher","first-page":"103493","DOI":"10.1016\/j.mcn.2020.103493","volume":"105","author":"TJ Wenzel","year":"2020","unstructured":"Wenzel TJ, et al. Short-chain fatty acids (SCFAs) alone or in combination regulate select immune functions of microglia-like cells. Mol Cell Neurosci. 2020;105:103493.","journal-title":"Mol Cell Neurosci"},{"issue":"1","key":"8395_CR134","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1038\/s41598-022-27086-x","volume":"13","author":"ME Caetano-Silva","year":"2023","unstructured":"Caetano-Silva ME, et al. Inhibition of inflammatory microglia by dietary fiber and short-chain fatty acids. Sci Rep. 2023;13(1):2819.","journal-title":"Sci Rep"},{"issue":"3","key":"8395_CR135","doi-asserted-by":"publisher","first-page":"e12963","DOI":"10.1111\/jne.12963","volume":"33","author":"SI Munesue","year":"2021","unstructured":"Munesue SI, et al. Transport of oxytocin to the brain after peripheral administration by membrane-bound or soluble forms of receptors for advanced glycation end-products. J Neuroendocrinol. 2021;33(3):e12963.","journal-title":"J Neuroendocrinol"},{"issue":"1","key":"8395_CR136","doi-asserted-by":"publisher","first-page":"7883","DOI":"10.1038\/s41598-017-07949-4","volume":"7","author":"H Higashida","year":"2017","unstructured":"Higashida H, et al. Intestinal transepithelial permeability of oxytocin into the blood is dependent on the receptor for advanced glycation end products in mice. Sci Rep. 2017;7(1):7883.","journal-title":"Sci Rep"},{"issue":"5","key":"8395_CR137","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.4049\/jimmunol.1002253","volume":"186","author":"Y Yamamoto","year":"2011","unstructured":"Yamamoto Y, et al. Septic shock is associated with receptor for advanced glycation end products ligation of LPS. J Immunol. 2011;186(5):3248\u201357.","journal-title":"J Immunol"},{"key":"8395_CR138","doi-asserted-by":"crossref","unstructured":"Mastrocola R, et al. Effects of exogenous dietary advanced glycation end products on the cross-talk mechanisms linking microbiota to metabolic inflammation. Nutrients. 2020;12(9).","DOI":"10.3390\/nu12092497"},{"issue":"7\u20138","key":"8395_CR139","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1016\/j.nut.2012.01.007","volume":"28","author":"YM Al-Farsi","year":"2012","unstructured":"Al-Farsi YM, et al. Effect of suboptimal breast-feeding on occurrence of autism: a case-control study. Nutrition. 2012;28(7\u20138):e27\u201332.","journal-title":"Nutrition"},{"key":"8395_CR140","doi-asserted-by":"crossref","unstructured":"Westmark CJ. Consumption of breast milk is associated with decreased prevalence of Autism in fragile X syndrome. Nutrients. 2021;13(6).","DOI":"10.3390\/nu13061785"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08395-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08395-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08395-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:03:37Z","timestamp":1790813017000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08395-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":140,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8395"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08395-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"<b>Consent for publication<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1227"}}